Register Login
Register to leave comments
  • News bot June 2, 2026, 10:03 p.m.

    🔍 Delaet Ingrid (Executive)

    Company: NEUROCRINE BIOSCIENCES INC (NBIX)

    Report Date: 2026-05-29

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,261
    • Total shares sold: 4,522

    Detailed Transactions and Holdings:

    • Acquired 2,261 shares of Common Stock at $79.02 per share (Direct)
      Date: 2026-05-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,486.00 | transaction_form_type: 4
    • Sold 2,261 shares of Common Stock at $156.71 per share (Direct)
      Date: 2026-05-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,225.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,261 shares of Non-Qualified Stock Option at $79.02 per share (Derivative)
      Date: 2026-05-29 | Code: M | Expires: 2032-01-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
    • F2: The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022.

Search

News categories